# Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

> **NCT02842424** · PHASE4 · RECRUITING · sponsor: **University of Nebraska** · enrollment: 70 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT02842424
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-02-25
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02842424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02842424, "Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02842424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*